
Sign up to save your podcasts
Or
Cast:
Joel Topf
Jennie Lin
Samira Farouk
Swapnil Hiremath
Show Notes:
NephJC coverage of SONAR: http://www.nephjc.com/news/sonar
SONAR in PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30995972
Avosentan for overt diabetic nephropathy, the ASCEND trial: https://www.ncbi.nlm.nih.gov/pubmed/20167702
RADAR coverage at NephJC, May 2014: http://www.nephjc.com/atrasentan
RADAR in PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24722445/
Google Hangout on RADAR: https://www.youtube.com/watch?v=pkkQbb-isog&feature=youtu.be
Vlado Perkovic: https://twitter.com/VladoPerkovic
SONAR: https://en.wikipedia.org/wiki/Sonar
Nephmadness adaptive trial: https://ajkdblog.org/2016/03/10/nephmadness-2016-statistics-in-nephrology-region/#adaptive
KIDNEYcon adaptive trial tweet thread: https://twitter.com/hswapnil/status/1117194018331471873?s=21
Excellent NEJM review on adaptive trials: https://www.nejm.org/doi/10.1056/NEJMra1510061
Potential role of Adaptive trials in AKI: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869991/
BNP levels in CKD: https://cjasn.asnjournals.org/content/3/6/1644
Generalizability from Wikipedia: https://en.wikipedia.org/wiki/Generalizability_theory
Anemia (and other adverse effects) of Endothelin antagonists: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210319/
Data safety monitoring boards: https://www.nidcr.nih.gov/research/human-subjects-research/interventional-studies/data-and-safety-monitoring-board-guidelines
AbbVie Allergen Merger: https://www.barrons.com/articles/abbvie-allergan-merger-pharma-deals-takeda-celgene-bristol-myers-squibb-51563890831
Tangri Kidney Failure Risk Equation: https://qxmd.com/calculate/calculator_308/kidney-failure-risk-equation-4-variable
Fragility index paper: https://www.ncbi.nlm.nih.gov/m/pubmed/24508144/
LITFL write up: https://litfl.com/fragility-index/
Calculator: https://clincalc.com/Stats/FragilityIndex.aspx
CANVAS Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa1811744
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study by David Juurlink et al.: https://www.nejm.org/doi/full/10.1056/NEJMoa040135
Vinay Prasad: https://en.wikipedia.org/wiki/Vinay_Prasad
Classic mouse studies looking at endothelin: https://www.jci.org/articles/view/119297/pdf
https://www.ncbi.nlm.nih.gov/pubmed/8377387/
https://diabetes.diabetesjournals.org/content/65/8/2429
Nice reviews:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698004/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216619/
Review of vascular effects:
https://www.ncbi.nlm.nih.gov/pubmed/28223322
4.9
166166 ratings
Cast:
Joel Topf
Jennie Lin
Samira Farouk
Swapnil Hiremath
Show Notes:
NephJC coverage of SONAR: http://www.nephjc.com/news/sonar
SONAR in PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30995972
Avosentan for overt diabetic nephropathy, the ASCEND trial: https://www.ncbi.nlm.nih.gov/pubmed/20167702
RADAR coverage at NephJC, May 2014: http://www.nephjc.com/atrasentan
RADAR in PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24722445/
Google Hangout on RADAR: https://www.youtube.com/watch?v=pkkQbb-isog&feature=youtu.be
Vlado Perkovic: https://twitter.com/VladoPerkovic
SONAR: https://en.wikipedia.org/wiki/Sonar
Nephmadness adaptive trial: https://ajkdblog.org/2016/03/10/nephmadness-2016-statistics-in-nephrology-region/#adaptive
KIDNEYcon adaptive trial tweet thread: https://twitter.com/hswapnil/status/1117194018331471873?s=21
Excellent NEJM review on adaptive trials: https://www.nejm.org/doi/10.1056/NEJMra1510061
Potential role of Adaptive trials in AKI: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869991/
BNP levels in CKD: https://cjasn.asnjournals.org/content/3/6/1644
Generalizability from Wikipedia: https://en.wikipedia.org/wiki/Generalizability_theory
Anemia (and other adverse effects) of Endothelin antagonists: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210319/
Data safety monitoring boards: https://www.nidcr.nih.gov/research/human-subjects-research/interventional-studies/data-and-safety-monitoring-board-guidelines
AbbVie Allergen Merger: https://www.barrons.com/articles/abbvie-allergan-merger-pharma-deals-takeda-celgene-bristol-myers-squibb-51563890831
Tangri Kidney Failure Risk Equation: https://qxmd.com/calculate/calculator_308/kidney-failure-risk-equation-4-variable
Fragility index paper: https://www.ncbi.nlm.nih.gov/m/pubmed/24508144/
LITFL write up: https://litfl.com/fragility-index/
Calculator: https://clincalc.com/Stats/FragilityIndex.aspx
CANVAS Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa1811744
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study by David Juurlink et al.: https://www.nejm.org/doi/full/10.1056/NEJMoa040135
Vinay Prasad: https://en.wikipedia.org/wiki/Vinay_Prasad
Classic mouse studies looking at endothelin: https://www.jci.org/articles/view/119297/pdf
https://www.ncbi.nlm.nih.gov/pubmed/8377387/
https://diabetes.diabetesjournals.org/content/65/8/2429
Nice reviews:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698004/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216619/
Review of vascular effects:
https://www.ncbi.nlm.nih.gov/pubmed/28223322
133 Listeners
314 Listeners
489 Listeners
278 Listeners
3,318 Listeners
1,113 Listeners
191 Listeners
713 Listeners
512 Listeners
349 Listeners
248 Listeners
426 Listeners
250 Listeners
366 Listeners
136 Listeners